Assesment of Knowledge,Attitude and Practice of Pregnant Women Regarding Iron,Folic Acid and Multivitamins at AlMonshah District.
NCT05477914 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2022-07-28
Summary
Anaemia is defined as the lack of functioning red blood cells (RBCs) that leads to a decrease in the ability to carry oxygen causing a lot of complications during life time.
Iron deficiency anaemia is a main public health problem in all countries. Over 30% of the world's population had anaemia; 4.3%-20% and 30%-48% respectively in developed and developing countries are affected by iron deficiency anaemia. Globally, it is estimated that roughly 38% of pregnant females, 29% non-pregnant women, and 29% of all females of reproductive age are diagnosed to have anaemia .
WHO suggested a standard daily dose of 30 to 60 mg of iron and 400 µg of folic acid supplements to prevent anaemia in pregnancy. This dose of iron and folic acid should be taken ideally before gestation with the earliest possible time and must be continued throughout the gestational period.
During pregnancy it is important to take adequate nutrition which is essential for optimal growth of the foetus and decrease in the incidence of congenital anomalies. adequate dietary intake of proteins and energy is not enough for normal weight of the new-born, decrease in vitamins and minerals can adversely affect the weight of the new- born .
The prevalence of neural tube defects, low-birth weights, small babies for gestational age and maternal anaemia can be reduced by adequate intake of iron and folic acid supplements during pregnancy. A lot of studies show the same positive results for the intake of multivitamins ,but iron and folic acid are the most important .
A lot of studies show the importance of the relationship between iron and folic acid supplement or multivitamins intake and the socio-economic factors as age, level of education, residence, marital status, parity, economic status, prenatal circumstances. There are association between more intake of supplements during pregnancy and a higher socioeconomic levels , level of education and use of prenatal medical services in studies conducted in Finland . The detection of anaemia in pregnancy is based on the examination of haemoglobin (Hb) levels at the first antenatal care visit.
If the haemoglobin level is \<11.9%, the pregnant woman is declared anaemic and should be given supplements of 60 mg iron tablets and 0.5 mg folic acid. This supplement is taken regularly 1 tablet per day for 90 consecutive days. If the haemoglobin level is still \<11.9%, then the administration of iron tablets is continued. However, in practice, not all pregnant women take tablets regularly. This could be due to inadequate knowledge about the importance of iron tablets for pregnancy.
Conditions
- Pregnancy Related
Interventions
- OTHER
-
questionnaire
questionnare about nutritional knowledge of pregnant women
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 49 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-31
- Primary Completion
- 2023-02-28
- Completion
- 2023-02-28
Countries
- Egypt
Study Locations
More Related Trials
-
Amino Acid Chelated Iron Versus Ferrous Fumarate in the Treatment of Iron Deficiency Anemia With Pregnancy: Randomized Controlled Trial
NCT03830034 ·Status: UNKNOWN ·Phase: PHASE4
-
Lactoferrin With Ferrous Gluconate Versus Ferrous Gluconate in Treatment of Iron Deficiency Anemia During Pregnancy
NCT06252103 ·Status: COMPLETED ·Phase: PHASE4
-
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement
NCT02957643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia
NCT05921968 ·Status: UNKNOWN ·Phase: PHASE4
-
Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women
NCT03212781 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Health Information Package Program on Knowledge and Compliance Among Pregnant Women With Anemia
NCT04661865 ·Status: COMPLETED ·Phase: NA
-
Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia
NCT07340450 ·Status: COMPLETED ·Phase: NA
-
Hemoglobinopathy Nursing Program and Pediatric Nursing Students
NCT05389891 ·Status: COMPLETED ·Phase: NA
-
Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
NCT04253626 ·Status: COMPLETED ·Phase: PHASE3
-
Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy
NCT03484845 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Lactoferrin Versus Ferrous Sulphate for the Treatment of Iron Deficiency Anemia During Pregnancy
NCT03456258 ·Status: COMPLETED ·Phase: NA
-
Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction
NCT04343170 ·Status: COMPLETED ·Phase: NA
-
Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients
NCT06708728 ·Status: NOT_YET_RECRUITING
-
Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.
NCT07110935 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Heavy Menstrual Bleeding and Iron Deficiency Anemia
NCT05079815 ·Status: UNKNOWN
-
The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalassemia Major
NCT02984475 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment Adherence and Fatigue in Iron Deficiency
NCT05909891 ·Status: COMPLETED ·Phase: NA
-
Clinical Study Evaluating the Efficacy of Iron Proteinsuccinylate Oral Solution(FERPLEX) in Women With Gynecologic Iron Deficiency Anemia
NCT05192291 ·Status: UNKNOWN
-
Lactoferrin Versus Ferrous Sulfate in Iron-deficiency During Pregnancy
NCT03759353 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Cognitive Function and Quality of Life in Thalassemic Children at Sohag University Hospital
NCT06058260 ·Status: NOT_YET_RECRUITING
-
Nonpharmacological Approaches and Parental Education in Children With Sickle Cell Disease
NCT04121247 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
NCT00354484 ·Status: COMPLETED ·Phase: PHASE3
-
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
NCT03341338 ·Status: COMPLETED
-
Iron Supplementation Using Total Dose Infusion and Oral Routes for Treatment of Iron Deficiency Anemia in Pregnancy
NCT02086838 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Deficiency Anemia, Iron Supplementation and Genomic Stability in Infants
NCT03359447 ·Status: UNKNOWN ·Phase: PHASE4